A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology
2022 · Nature Cancer · 365 citations
https://doi.org/10.1038/s43018-022-00337-6
S
Sandra D. Scherer
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
53
Papers
1.6K
Citations
17
h-index
20
i10-index
Sandra D. Scherer is an academic researcher from University of Utah. The author has contributed to research in topics: Cancer Cells and Metastasis & Cancer Genomics and Diagnostics & 3D Printing in Biomedical Research. The author has an h-index of 17, co-authored 46 publications.
ORCID: 0000-0002-7943-8595Papers by this author
worksConservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts
2021 · Nature Genetics · 189 citations
https://doi.org/10.1038/s41588-020-00750-6
Macrophage-Induced Lymphangiogenesis and Metastasis following Paclitaxel Chemotherapy Is Regulated by VEGFR3
2016 · Cell Reports · 112 citations
https://doi.org/10.1016/j.celrep.2016.09.083
Multiparametric quantitative phase imaging for real-time, single cell, drug screening in breast cancer
2022 · Communications Biology · 51 citations
https://doi.org/10.1038/s42003-022-03759-1
Breast cancer PDxO cultures for drug discovery and functional precision oncology
2023 · STAR Protocols · 16 citations
https://doi.org/10.1016/j.xpro.2023.102402
Orphan Nuclear Receptor 4A1 (NR4A1) and NR4A2 are Endogenous Regulators of CD71 and Their Ligands Induce Ferroptosis in Breast Cancer
2025 · Research Square · 0 citations
https://doi.org/10.21203/rs.3.rs-6214709/v1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat